Kura Oncology Inc Asset Resilience Ratio

Latest as of June 2026: 76.35%

Kura Oncology Inc asset resilience ratio. Kura Oncology Inc (KURA) has an Asset Resilience Ratio of 76.35% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Kura Oncology Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$448.78 Million

Cash + Short-term Investments

Total Assets

$587.79 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Kura Oncology Inc (2015–2025)

Asset resilience ratio of Kura Oncology Inc from 2015 to 2025. This chart shows how Kura Oncology Inc's Asset Resilience Ratio has changed over time. Read Kura Oncology Inc (KURA) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Kura Oncology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Kura Oncology Inc (KURA) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$448.78 Million	76.35%
Total Liquid Assets	$448.78 Million	76.35%

Asset Resilience Insights

Very High Liquidity: Kura Oncology Inc maintains exceptional liquid asset reserves at 76.35% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Kura Oncology Inc Industry Peers by Asset Resilience Ratio

Compare Kura Oncology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Kura Oncology Inc Asset Resilience Ratio by Year (2015–2025)

Kura Oncology Inc asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Kura Oncology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	70.17%	$518.14 Million	$738.36 Million	+4.01pp
2024-12-31	66.16%	$502.93 Million	$760.16 Million	-19.96pp
2023-12-31	86.12%	$386.64 Million	$448.94 Million	+1.49pp
2022-12-31	84.63%	$386.18 Million	$456.31 Million	+4.62pp
2021-12-31	80.01%	$427.29 Million	$534.05 Million	+32.45pp
2020-12-31	47.56%	$307.83 Million	$647.21 Million	-39.54pp
2019-12-31	87.10%	$210.76 Million	$241.97 Million	-2.20pp
2018-12-31	89.30%	$162.87 Million	$182.38 Million	+4.05pp
2017-12-31	85.25%	$81.71 Million	$95.85 Million	+2.09pp
2016-12-31	83.16%	$58.06 Million	$69.82 Million	+2.59pp
2015-12-31	80.57%	$70.30 Million	$87.26 Million	--

pp = percentage points

About Kura Oncology Inc

NASDAQ:KURA USA Biotechnology

Market Cap

$870.92 Million

Market Cap Rank

#9184 Global

#2594 in USA

Share Price

$9.79

Change (1 day)

-4.58%

52-Week Range

$7.40 - $13.59

All Time High

$41.62